Extended Data Fig. 7: UACR over time in participants with SGLT2i use at baseline (a) or without (b). | Nature Medicine

Extended Data Fig. 7: UACR over time in participants with SGLT2i use at baseline (a) or without (b).

From: Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial

Extended Data Fig. 7

Observed data from the in-trial period. Error bars are +/– the standard error of the mean on the logarithmic scale back-transformed to natural scale with the exponential. Numbers shown in the lower panel represent the number of participants contributing to the means. SGLT2i, sodium-glucose co-transporter-2 inhibitors; UACR, urine albumin-to-creatinine ratio.

Back to article page